Atlas Trials

Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment

Clinical trial NCT01724723 · UNKNOWN

Trial details

NCT number
NCT01724723
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HepatitisTuberculosishepatitisB
Start date
2012-12-01
Primary completion
2014-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.